Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Shillingford

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Physiology. Renal Physiology|February 16, 2023
Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1Jonathan M Shillingford, James A Shayman
Journal of the American Society of Nephrology : JASN|January 16, 2010
Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1Jonathan M Shillingford, Klaus B Piontek, Gregory G Germino, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2012
Folate-conjugated rapamycin slows progression of polycystic kidney diseaseJonathan M Shillingford, Christopher P Leamon, Iontcho R Vlahov, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesisJonathan M Shillingford, Keiko Miyoshi, Michael Flagella, et al.
Clinical Kidney Journal|December 25, 2018
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney diseaseThomas Weimbs, Jonathan M Shillingford, Jacob Torres, et al.
Nephrology (Carlton, Vic.)|June 26, 2012
Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetusCherie Stayner, Justin Shields, Lynn Slobbe, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 22, 2003
Proteotyping of mammary tissue from transgenic and gene knockout mice with immunohistochemical markers: a tool to define developmental lesionsJonathan M Shillingford, Keiko Miyoshi, Gertraud W Robinson, et al.
Development (Cambridge, England)|September 5, 2003
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5Weiwen Long, Kay-Uwe Wagner, K C Kent Lloyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
Polycystin-1 regulates STAT activity by a dual mechanismJeffrey J Talbot, Jonathan M Shillingford, Shivakumar Vasanth, et al.
Journal of Lipid Research|June 4, 2021
Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosisVania Hinkovska-Galcheva, Taylour Treadwell, Jonathan M Shillingford, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Renal Physiology|February 16, 2023
Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1Jonathan M Shillingford, James A Shayman
Journal of the American Society of Nephrology : JASN|January 16, 2010
Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1Jonathan M Shillingford, Klaus B Piontek, Gregory G Germino, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2012
Folate-conjugated rapamycin slows progression of polycystic kidney diseaseJonathan M Shillingford, Christopher P Leamon, Iontcho R Vlahov, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesisJonathan M Shillingford, Keiko Miyoshi, Michael Flagella, et al.
Clinical Kidney Journal|December 25, 2018
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney diseaseThomas Weimbs, Jonathan M Shillingford, Jacob Torres, et al.
Nephrology (Carlton, Vic.)|June 26, 2012
Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetusCherie Stayner, Justin Shields, Lynn Slobbe, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 22, 2003
Proteotyping of mammary tissue from transgenic and gene knockout mice with immunohistochemical markers: a tool to define developmental lesionsJonathan M Shillingford, Keiko Miyoshi, Gertraud W Robinson, et al.
Development (Cambridge, England)|September 5, 2003
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5Weiwen Long, Kay-Uwe Wagner, K C Kent Lloyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
Polycystin-1 regulates STAT activity by a dual mechanismJeffrey J Talbot, Jonathan M Shillingford, Shivakumar Vasanth, et al.
Journal of Lipid Research|June 4, 2021
Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosisVania Hinkovska-Galcheva, Taylour Treadwell, Jonathan M Shillingford, et al.
Pageof 3